NCT03138031View on ClinicalTrials.gov

Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular Carcinoma

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

May 1, 2018

Study Completion Date

May 30, 2018

Conditions
Hepatocellular Carcinoma Non-resectable
Interventions
PROCEDURE

Percutaneous ethanol alcohol injection

"Day-case procedure; weekly sessions; uses absolute alcohol; under close monitoring; maximum dose of 30 ml; no anesthesia needed and a maximum pain score of 8 limits the procedure. Post-procedure analgesia may be required."

Trial Locations (1)

11111

Ribat University Hospital, Khartoum

All Listed Sponsors
lead

The National Ribat University

OTHER

NCT03138031 - Percutaneous Ethanol Alcohol Injection for the Large and Unresectable Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter